About this trial
Urinary incontinence is a common and distressing medical condition which affects 26% of women in developing countries.Globally upto 54% women suffer from pelvic organ prolapse and stress urinary incontinence concomitantly.Women with coexisting stress incontinence have a 40% risk of undergoing subsequent surgery for postoperative stress incontinence and woem with occult incontinence have a 15% risk.Overall,there is sufficient evidence that for women who are symptomatic of stress incontinence and prolapse,concomitant vaginal surgery for both problems is beneficial for reducing postoperative incontinence.However,it must be borne in mind that in woen undergoing vaginal prolapse surgery alone,almost 1/3 may experience cure of incontinence symptoms and despite concomitant continence surgery,stress urinary incontinence persist in approximately 1/3 of women.This study will be conducted to assess whether women with polpase and stress urinary incontinence could benefit from combined surgery in regards of requiring further surgery for stress incontinence.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adult females 41-83 years age presenting with concurrent prolapse and stress urinary incontinence willing to participate in the study.
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
anti incontinence surgery
Procedure/Surgeryanti incontinence surgery with prolapse surgery will be performed simultaneously
Treatment groups
Trial outcomes
Primary outcomes
symptomatic stress urinary incontinence requiring surgery at six months
Secondary outcomes
quality of life parameters.It will be assessed using ICIQ-UI short form questionnaires
0-12 score will show improved quality of life while 13-21 will show impaired quality
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: